ArticleCardio-oncology (London, England)2024

Cardiovascular events in CML patients treated with Nilotinib: validation of the HFA-ICOS baseline risk score.

Fiona Fernando et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.